Single nucleotide polymorphism of PIK3CA and its interaction with the environment are risk factors for Chinese Han ovarian cancer

The PI3K pathway is an important signaling network that regulates key cell functions such as cell growth, proliferation and survival. PIK3CA mutations are found in a variety of human cancers. This study aimed to analyze the effect of interactions between PIK3CA rs2699887, rs3976507, rs6443626 single...

Full description

Saved in:
Bibliographic Details
Published inPathology, research and practice Vol. 215; no. 9; p. 152520
Main Authors Zhang, Hui, Zhou, Li
Format Journal Article
LanguageEnglish
Published Germany Elsevier GmbH 01.09.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The PI3K pathway is an important signaling network that regulates key cell functions such as cell growth, proliferation and survival. PIK3CA mutations are found in a variety of human cancers. This study aimed to analyze the effect of interactions between PIK3CA rs2699887, rs3976507, rs6443626 single nucleotide polymorphisms (SNPs), and the environment on the risk of Chinese Han ovarian cancer. Sanger sequencing was used to analyze the PIK3CA rs2699887, rs3976507, rs6443626 genotypes in 350 Chinese Han ovarian cancer patients and 350 control individuals, and the expression of PIK3CA protein was detected in 117 ovarian cancer patients. In subjects with age ≥60 years, Number liveborn ≤ 3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of the rs2699887 T allele carriers were increased (all p < 0.05). In subjects with obesity (BMI ≥ 24 kg/m2), Number liveborn ≤3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of rs3976507 T allele carriers and rs6443626 C allele carriers were increased (all p < 0.05). PIK3CA protein expression level in PIK3CA rs2699887 C > T, rs3976507 C > T, rs6443626 T > C locus homozygotes was significantly higher than that in heterozygotes (p <  0.05). Interaction between PIK3CA rs2699887 SNP and age, number of liveborn, tobacco, alcohol, a family history of ovarian cancer and other factors are associated with ovarian cancer risk. Interaction between PIK3CA rs3976507 and rs6443626 loci, and factors such as BMI, number of liveborn, tobacco, alcohol, and family history of ovarian cancer are associated with ovarian cancer risk.
AbstractList The PI3K pathway is an important signaling network that regulates key cell functions such as cell growth, proliferation and survival. PIK3CA mutations are found in a variety of human cancers. This study aimed to analyze the effect of interactions between PIK3CA rs2699887, rs3976507, rs6443626 single nucleotide polymorphisms (SNPs), and the environment on the risk of Chinese Han ovarian cancer.BACKGROUND AND PURPOSEThe PI3K pathway is an important signaling network that regulates key cell functions such as cell growth, proliferation and survival. PIK3CA mutations are found in a variety of human cancers. This study aimed to analyze the effect of interactions between PIK3CA rs2699887, rs3976507, rs6443626 single nucleotide polymorphisms (SNPs), and the environment on the risk of Chinese Han ovarian cancer.Sanger sequencing was used to analyze the PIK3CA rs2699887, rs3976507, rs6443626 genotypes in 350 Chinese Han ovarian cancer patients and 350 control individuals, and the expression of PIK3CA protein was detected in 117 ovarian cancer patients.METHODSSanger sequencing was used to analyze the PIK3CA rs2699887, rs3976507, rs6443626 genotypes in 350 Chinese Han ovarian cancer patients and 350 control individuals, and the expression of PIK3CA protein was detected in 117 ovarian cancer patients.In subjects with age ≥60 years, Number liveborn ≤ 3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of the rs2699887 T allele carriers were increased (all p < 0.05). In subjects with obesity (BMI ≥ 24 kg/m2), Number liveborn ≤3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of rs3976507 T allele carriers and rs6443626 C allele carriers were increased (all p < 0.05). PIK3CA protein expression level in PIK3CA rs2699887 C > T, rs3976507 C > T, rs6443626 T > C locus homozygotes was significantly higher than that in heterozygotes (p <  0.05).RESULTSIn subjects with age ≥60 years, Number liveborn ≤ 3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of the rs2699887 T allele carriers were increased (all p < 0.05). In subjects with obesity (BMI ≥ 24 kg/m2), Number liveborn ≤3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of rs3976507 T allele carriers and rs6443626 C allele carriers were increased (all p < 0.05). PIK3CA protein expression level in PIK3CA rs2699887 C > T, rs3976507 C > T, rs6443626 T > C locus homozygotes was significantly higher than that in heterozygotes (p <  0.05).Interaction between PIK3CA rs2699887 SNP and age, number of liveborn, tobacco, alcohol, a family history of ovarian cancer and other factors are associated with ovarian cancer risk. Interaction between PIK3CA rs3976507 and rs6443626 loci, and factors such as BMI, number of liveborn, tobacco, alcohol, and family history of ovarian cancer are associated with ovarian cancer risk.CONCLUSIONInteraction between PIK3CA rs2699887 SNP and age, number of liveborn, tobacco, alcohol, a family history of ovarian cancer and other factors are associated with ovarian cancer risk. Interaction between PIK3CA rs3976507 and rs6443626 loci, and factors such as BMI, number of liveborn, tobacco, alcohol, and family history of ovarian cancer are associated with ovarian cancer risk.
The PI3K pathway is an important signaling network that regulates key cell functions such as cell growth, proliferation and survival. PIK3CA mutations are found in a variety of human cancers. This study aimed to analyze the effect of interactions between PIK3CA rs2699887, rs3976507, rs6443626 single nucleotide polymorphisms (SNPs), and the environment on the risk of Chinese Han ovarian cancer. Sanger sequencing was used to analyze the PIK3CA rs2699887, rs3976507, rs6443626 genotypes in 350 Chinese Han ovarian cancer patients and 350 control individuals, and the expression of PIK3CA protein was detected in 117 ovarian cancer patients. In subjects with age ≥60 years, Number liveborn ≤ 3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of the rs2699887 T allele carriers were increased (all p < 0.05). In subjects with obesity (BMI ≥ 24 kg/m2), Number liveborn ≤3, no smoking, no alcohol, and no family history of ovarian cancer, the risk of ovarian cancer of rs3976507 T allele carriers and rs6443626 C allele carriers were increased (all p < 0.05). PIK3CA protein expression level in PIK3CA rs2699887 C > T, rs3976507 C > T, rs6443626 T > C locus homozygotes was significantly higher than that in heterozygotes (p <  0.05). Interaction between PIK3CA rs2699887 SNP and age, number of liveborn, tobacco, alcohol, a family history of ovarian cancer and other factors are associated with ovarian cancer risk. Interaction between PIK3CA rs3976507 and rs6443626 loci, and factors such as BMI, number of liveborn, tobacco, alcohol, and family history of ovarian cancer are associated with ovarian cancer risk.
ArticleNumber 152520
Author Zhou, Li
Zhang, Hui
Author_xml – sequence: 1
  givenname: Hui
  surname: Zhang
  fullname: Zhang, Hui
  organization: Department of Gynecology, Hangzhou Fuyang Women and Children Hospital, No. 25 Hengliangting Road, Fuyang District, Hangzhou, Zhejiang Province, China
– sequence: 2
  givenname: Li
  surname: Zhou
  fullname: Zhou, Li
  email: zhouli820704@126.com
  organization: Department of Gynecology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31288947$$D View this record in MEDLINE/PubMed
BookMark eNp9kTtvFDEUhS0URDaBH0CDXNLMxq95iSpaAYkSCSSgtjz2NXuXGXuwvYtS8s-Z1SYNRaqrK33fKc65IGchBiDkLWdrznhztVvPaV4Lxvs1r0Ut2Auy4g3vKtZIfkZWTCpVMSm7c3KR844x1jLFX5FzyUXX9apdkb_fMPwcgYa9HSEWdEDnOD5MMc1bzBONnn69vZOba2qCo1gyxVAgGVswBvoHy5aWLVAIB0wxTBAKNQlowvyL-oWKKVMfE91sMUAGemMCjQeTcLnWBAvpNXnpzZjhzeO9JD8-ffy-uanuv3y-3VzfV1bWslSq8-1gjAcphHC9N2KoO-CiFxJ8V5tWquWpXc8G25nODcpYpYx3DeNeDlxekven3DnF33vIRU-YLYyjCRD3WQtR16rpFWML-u4R3Q8TOD0nnEx60E-1LUB7AmyKOSfw2mIxx0pKMjhqzvRxIL1b1FkfB9KngRaT_2c-hT_nfDg5sNRzQEg6W4SlO4cJbNEu4jP2P_d-qdQ
CitedBy_id crossref_primary_10_7717_peerj_12377
crossref_primary_10_1142_S0192415X22500239
crossref_primary_10_1016_j_scitotenv_2020_138314
crossref_primary_10_1186_s13048_021_00831_y
crossref_primary_10_12677_ACM_2020_1011430
crossref_primary_10_1016_j_jhazmat_2019_121361
crossref_primary_10_3389_fonc_2021_564296
Cites_doi 10.1007/s13277-016-4924-2
10.1038/nrd4204
10.1158/1055-9965.EPI-15-1039
10.1016/j.ejca.2016.04.016
10.1158/1078-0432.CCR-13-1093
10.1111/liv.13055
10.1038/onc.2015.377
10.1038/nrd2926
10.1038/ncomms12799
10.1371/journal.pgen.1003212
10.2147/OTT.S97668
10.4161/cbt.8.1.7209
10.1016/j.ygyno.2016.07.092
10.3389/fendo.2018.00402
10.1016/j.pharmthera.2017.02.037
10.1371/journal.pone.0158801
10.1007/s00280-018-3543-6
10.1016/j.ygyno.2017.10.001
10.1016/S1535-6108(03)00248-4
10.1016/j.ijgo.2007.11.004
10.1126/science.296.5573.1655
10.1158/1055-9965.EPI-17-0315
10.1242/jcs.013029
10.18632/oncotarget.25513
10.1002/gepi.21921
10.1158/1055-9965.EPI-12-1030-T
10.1158/1078-0432.CCR-04-2142
ContentType Journal Article
Copyright 2019
Copyright © 2019. Published by Elsevier GmbH.
Copyright_xml – notice: 2019
– notice: Copyright © 2019. Published by Elsevier GmbH.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.prp.2019.152520
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1618-0631
ExternalDocumentID 31288947
10_1016_j_prp_2019_152520
S0344033819300810
Genre Journal Article
GroupedDBID ---
--K
--M
.55
.GJ
.~1
0R~
123
1B1
1~.
1~5
29O
3O-
3V.
4.4
457
4CK
4G.
53G
5RE
5VS
7-5
71M
7X7
88E
88I
8AF
8FE
8FH
8FI
8FJ
8G5
8P~
8R4
8R5
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AAKPP
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABBQC
ABFNM
ABGSF
ABLJU
ABLVK
ABMAC
ABMZM
ABUDA
ABUWG
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACGOD
ACPRK
ACRLP
ADBBV
ADEZE
ADKUU
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AENEX
AFKRA
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AHMBA
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
AZQEC
BBNVY
BCR
BCU
BEC
BENPR
BHPHI
BKOJK
BLC
BLXMC
BNPGV
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DOVZS
DU5
DWQXO
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-Q
GBLVA
GNUQQ
GUQSH
HCIFZ
HMCUK
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
LCYCR
LK8
M1P
M2O
M2P
M2Q
M41
M7P
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PADUT
PC.
PEA
PQQKQ
PRG
PROAC
PSQYO
Q2X
Q38
R2-
RIG
ROL
RPZ
S0X
SDF
SDG
SES
SEW
SJFOW
SSH
SSU
SSZ
T5I
T5J
T5K
UDS
UKHRP
X7M
YCJ
ZA5
ZGI
ZXP
~G-
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACIEU
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ALIPV
ANKPU
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c353t-48f7baafe3222d9fa2b58e12923ef85a7341295d90bc8a8db4ac44afd601f3b13
IEDL.DBID .~1
ISSN 0344-0338
1618-0631
IngestDate Fri Jul 11 01:33:32 EDT 2025
Thu Apr 03 07:05:35 EDT 2025
Thu Apr 24 23:07:36 EDT 2025
Tue Jul 01 02:16:16 EDT 2025
Fri Feb 23 02:22:01 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Single nucleotide polymorphism
PIK3CA
Gene-environment interaction
Ovarian cancer
Language English
License Copyright © 2019. Published by Elsevier GmbH.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c353t-48f7baafe3222d9fa2b58e12923ef85a7341295d90bc8a8db4ac44afd601f3b13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 31288947
PQID 2255469400
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2255469400
pubmed_primary_31288947
crossref_citationtrail_10_1016_j_prp_2019_152520
crossref_primary_10_1016_j_prp_2019_152520
elsevier_sciencedirect_doi_10_1016_j_prp_2019_152520
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2019
2019-09-00
2019-Sep
20190901
PublicationDateYYYYMMDD 2019-09-01
PublicationDate_xml – month: 09
  year: 2019
  text: September 2019
PublicationDecade 2010
PublicationPlace Germany
PublicationPlace_xml – name: Germany
PublicationTitle Pathology, research and practice
PublicationTitleAlternate Pathol Res Pract
PublicationYear 2019
Publisher Elsevier GmbH
Publisher_xml – name: Elsevier GmbH
References Huang (bib0005) 2016; 63
Couch (bib0070) 2013; 9
Lee (bib0105) 2016; 7
Usset (bib0140) 2016; 25
Luo, Manning, Cantley (bib0090) 2003; 4
He (bib0040) 2016; 9
Kar (bib0015) 2018; 27
Amankwah (bib0075) 2015; 39
Le Naour (bib0100) 2018; 9
Vigorito (bib0080) 2016; 11
Astanehe (bib0135) 2008; 121
Fruman, Rommel (bib0055) 2014; 13
Odicino (bib0065) 2008; 101
Cheng (bib0115) 2016; 35
Cantley (bib0025) 2002; 296
Jones (bib0010) 2017; 147
Nicos (bib0035) 2016; 36
Citi (bib0120) 2018; 81
Wang (bib0045) 2016; 142
Dirican, Akkiprik, Ozer (bib0030) 2016; 37
Li (bib0125) 2013; 19
Wang (bib0110) 2016; 36
Kolasa (bib0130) 2009; 8
Liu (bib0050) 2009; 8
Dey, De, Leyland-Jones (bib0095) 2017; 175
Levine (bib0085) 2005; 11
Pearce (bib0020) 2013; 22
O’Brien (bib0060) 2018; 9
Nicos (10.1016/j.prp.2019.152520_bib0035) 2016; 36
Kar (10.1016/j.prp.2019.152520_bib0015) 2018; 27
He (10.1016/j.prp.2019.152520_bib0040) 2016; 9
Astanehe (10.1016/j.prp.2019.152520_bib0135) 2008; 121
Usset (10.1016/j.prp.2019.152520_bib0140) 2016; 25
Couch (10.1016/j.prp.2019.152520_bib0070) 2013; 9
Fruman (10.1016/j.prp.2019.152520_bib0055) 2014; 13
Luo (10.1016/j.prp.2019.152520_bib0090) 2003; 4
Jones (10.1016/j.prp.2019.152520_bib0010) 2017; 147
Le Naour (10.1016/j.prp.2019.152520_bib0100) 2018; 9
Citi (10.1016/j.prp.2019.152520_bib0120) 2018; 81
Wang (10.1016/j.prp.2019.152520_bib0110) 2016; 36
O’Brien (10.1016/j.prp.2019.152520_bib0060) 2018; 9
Dey (10.1016/j.prp.2019.152520_bib0095) 2017; 175
Huang (10.1016/j.prp.2019.152520_bib0005) 2016; 63
Liu (10.1016/j.prp.2019.152520_bib0050) 2009; 8
Amankwah (10.1016/j.prp.2019.152520_bib0075) 2015; 39
Wang (10.1016/j.prp.2019.152520_bib0045) 2016; 142
Lee (10.1016/j.prp.2019.152520_bib0105) 2016; 7
Levine (10.1016/j.prp.2019.152520_bib0085) 2005; 11
Cheng (10.1016/j.prp.2019.152520_bib0115) 2016; 35
Li (10.1016/j.prp.2019.152520_bib0125) 2013; 19
Cantley (10.1016/j.prp.2019.152520_bib0025) 2002; 296
Kolasa (10.1016/j.prp.2019.152520_bib0130) 2009; 8
Vigorito (10.1016/j.prp.2019.152520_bib0080) 2016; 11
Odicino (10.1016/j.prp.2019.152520_bib0065) 2008; 101
Dirican (10.1016/j.prp.2019.152520_bib0030) 2016; 37
Pearce (10.1016/j.prp.2019.152520_bib0020) 2013; 22
References_xml – volume: 63
  start-page: 1
  year: 2016
  end-page: 10
  ident: bib0005
  article-title: Incidence and mortality of gynaecological cancers: secular trends in urban Shanghai, China over 40 years
  publication-title: Eur. J. Cancer
– volume: 36
  start-page: 2243
  year: 2016
  end-page: 2249
  ident: bib0035
  article-title: PIK3CA mutations detected in patients with central nervous system metastases of non-small cell lung cancer
  publication-title: Anticancer Res.
– volume: 19
  start-page: 6252
  year: 2013
  end-page: 6260
  ident: bib0125
  article-title: Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer
  publication-title: Clin. Cancer Res.
– volume: 36
  start-page: 1176
  year: 2016
  end-page: 1186
  ident: bib0110
  article-title: Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade
  publication-title: Liver Int.
– volume: 22
  start-page: 880
  year: 2013
  end-page: 890
  ident: bib0020
  article-title: Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer
  publication-title: Cancer Epidemiol. Biomarkers Prev.
– volume: 147
  start-page: 705
  year: 2017
  end-page: 713
  ident: bib0010
  article-title: Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction
  publication-title: Gynecol. Oncol.
– volume: 13
  start-page: 140
  year: 2014
  end-page: 156
  ident: bib0055
  article-title: PI3K and cancer: lessons, challenges and opportunities
  publication-title: Nat. Rev. Drug Discov.
– volume: 4
  start-page: 257
  year: 2003
  end-page: 262
  ident: bib0090
  article-title: Targeting the PI3K-Akt pathway in human cancer: rationale and promise
  publication-title: Cancer Cell
– volume: 9
  start-page: 402
  year: 2018
  ident: bib0060
  article-title: Overview of MicroRNA biogenesis, mechanisms of actions, and circulation
  publication-title: Front. Endocrinol. (Lausanne)
– volume: 27
  start-page: 395
  year: 2018
  end-page: 404
  ident: bib0015
  article-title: Common genetic variation and susceptibility to ovarian cancer: current insights and future directions
  publication-title: Cancer Epidemiol. Biomarkers Prev.
– volume: 37
  start-page: 7033
  year: 2016
  end-page: 7045
  ident: bib0030
  article-title: Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer
  publication-title: Tumour Biol.
– volume: 11
  start-page: 2875
  year: 2005
  end-page: 2878
  ident: bib0085
  article-title: Frequent mutation of the PIK3CA gene in ovarian and breast cancers
  publication-title: Clin. Cancer Res.
– volume: 8
  start-page: 21
  year: 2009
  end-page: 26
  ident: bib0130
  article-title: PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients
  publication-title: Cancer Biol. Ther.
– volume: 142
  start-page: 548
  year: 2016
  end-page: 556
  ident: bib0045
  article-title: Combined inhibition of PI3K and PARP is effective in the treatment of ovarian cancer cells with wild-type PIK3CA genes
  publication-title: Gynecol. Oncol.
– volume: 121
  start-page: 664
  year: 2008
  end-page: 674
  ident: bib0135
  article-title: Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer
  publication-title: J. Cell. Sci.
– volume: 175
  start-page: 91
  year: 2017
  end-page: 106
  ident: bib0095
  article-title: PI3K-AKT-mTOR inhibitors in breast cancers: from tumor cell signaling to clinical trials
  publication-title: Pharmacol. Ther.
– volume: 11
  year: 2016
  ident: bib0080
  article-title: Fine-scale mapping at 9p22.2 identifies candidate causal variants that modify ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
  publication-title: PLoS One
– volume: 9
  start-page: 2329
  year: 2016
  end-page: 2335
  ident: bib0040
  article-title: Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer
  publication-title: Onco. Ther.
– volume: 35
  start-page: 2961
  year: 2016
  end-page: 2970
  ident: bib0115
  article-title: PIK3CA(H1047R)- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling
  publication-title: Oncogene
– volume: 8
  start-page: 627
  year: 2009
  end-page: 644
  ident: bib0050
  article-title: Targeting the phosphoinositide 3-kinase pathway in cancer
  publication-title: Nat. Rev. Drug Discov.
– volume: 25
  start-page: 780
  year: 2016
  end-page: 790
  ident: bib0140
  article-title: Assessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factors
  publication-title: Cancer Epidemiol. Biomarkers Prev.
– volume: 39
  start-page: 689
  year: 2015
  end-page: 697
  ident: bib0075
  article-title: Epithelial-mesenchymal transition (EMT) gene variants and epithelial ovarian cancer (EOC) risk
  publication-title: Genet. Epidemiol.
– volume: 296
  start-page: 1655
  year: 2002
  end-page: 1657
  ident: bib0025
  article-title: The phosphoinositide 3-kinase pathway
  publication-title: Science
– volume: 81
  start-page: 745
  year: 2018
  end-page: 754
  ident: bib0120
  article-title: Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro
  publication-title: Cancer Chemother. Pharmacol.
– volume: 9
  year: 2013
  ident: bib0070
  article-title: Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
  publication-title: PLoS Genet.
– volume: 7
  start-page: 12799
  year: 2016
  ident: bib0105
  article-title: Anks1a regulates COPII-mediated anterograde transport of receptor tyrosine kinases critical for tumorigenesis
  publication-title: Nat. Commun.
– volume: 9
  start-page: 27220
  year: 2018
  end-page: 27232
  ident: bib0100
  article-title: Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance
  publication-title: Oncotarget
– volume: 101
  start-page: 205
  year: 2008
  end-page: 210
  ident: bib0065
  article-title: History of the FIGO cancer staging system
  publication-title: Int. J. Gynaecol. Obstet.
– volume: 37
  start-page: 7033
  issue: 6
  year: 2016
  ident: 10.1016/j.prp.2019.152520_bib0030
  article-title: Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer
  publication-title: Tumour Biol.
  doi: 10.1007/s13277-016-4924-2
– volume: 13
  start-page: 140
  issue: 2
  year: 2014
  ident: 10.1016/j.prp.2019.152520_bib0055
  article-title: PI3K and cancer: lessons, challenges and opportunities
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd4204
– volume: 25
  start-page: 780
  issue: 5
  year: 2016
  ident: 10.1016/j.prp.2019.152520_bib0140
  article-title: Assessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factors
  publication-title: Cancer Epidemiol. Biomarkers Prev.
  doi: 10.1158/1055-9965.EPI-15-1039
– volume: 63
  start-page: 1
  year: 2016
  ident: 10.1016/j.prp.2019.152520_bib0005
  article-title: Incidence and mortality of gynaecological cancers: secular trends in urban Shanghai, China over 40 years
  publication-title: Eur. J. Cancer
  doi: 10.1016/j.ejca.2016.04.016
– volume: 19
  start-page: 6252
  issue: 22
  year: 2013
  ident: 10.1016/j.prp.2019.152520_bib0125
  article-title: Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-13-1093
– volume: 36
  start-page: 1176
  issue: 8
  year: 2016
  ident: 10.1016/j.prp.2019.152520_bib0110
  article-title: Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade
  publication-title: Liver Int.
  doi: 10.1111/liv.13055
– volume: 36
  start-page: 2243
  issue: 5
  year: 2016
  ident: 10.1016/j.prp.2019.152520_bib0035
  article-title: PIK3CA mutations detected in patients with central nervous system metastases of non-small cell lung cancer
  publication-title: Anticancer Res.
– volume: 35
  start-page: 2961
  issue: 23
  year: 2016
  ident: 10.1016/j.prp.2019.152520_bib0115
  article-title: PIK3CA(H1047R)- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling
  publication-title: Oncogene
  doi: 10.1038/onc.2015.377
– volume: 8
  start-page: 627
  issue: 8
  year: 2009
  ident: 10.1016/j.prp.2019.152520_bib0050
  article-title: Targeting the phosphoinositide 3-kinase pathway in cancer
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2926
– volume: 7
  start-page: 12799
  year: 2016
  ident: 10.1016/j.prp.2019.152520_bib0105
  article-title: Anks1a regulates COPII-mediated anterograde transport of receptor tyrosine kinases critical for tumorigenesis
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms12799
– volume: 9
  issue: 3
  year: 2013
  ident: 10.1016/j.prp.2019.152520_bib0070
  article-title: Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
  publication-title: PLoS Genet.
  doi: 10.1371/journal.pgen.1003212
– volume: 9
  start-page: 2329
  year: 2016
  ident: 10.1016/j.prp.2019.152520_bib0040
  article-title: Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer
  publication-title: Onco. Ther.
  doi: 10.2147/OTT.S97668
– volume: 8
  start-page: 21
  issue: 1
  year: 2009
  ident: 10.1016/j.prp.2019.152520_bib0130
  article-title: PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients
  publication-title: Cancer Biol. Ther.
  doi: 10.4161/cbt.8.1.7209
– volume: 142
  start-page: 548
  issue: 3
  year: 2016
  ident: 10.1016/j.prp.2019.152520_bib0045
  article-title: Combined inhibition of PI3K and PARP is effective in the treatment of ovarian cancer cells with wild-type PIK3CA genes
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2016.07.092
– volume: 9
  start-page: 402
  year: 2018
  ident: 10.1016/j.prp.2019.152520_bib0060
  article-title: Overview of MicroRNA biogenesis, mechanisms of actions, and circulation
  publication-title: Front. Endocrinol. (Lausanne)
  doi: 10.3389/fendo.2018.00402
– volume: 175
  start-page: 91
  year: 2017
  ident: 10.1016/j.prp.2019.152520_bib0095
  article-title: PI3K-AKT-mTOR inhibitors in breast cancers: from tumor cell signaling to clinical trials
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2017.02.037
– volume: 11
  issue: 7
  year: 2016
  ident: 10.1016/j.prp.2019.152520_bib0080
  article-title: Fine-scale mapping at 9p22.2 identifies candidate causal variants that modify ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0158801
– volume: 81
  start-page: 745
  issue: 4
  year: 2018
  ident: 10.1016/j.prp.2019.152520_bib0120
  article-title: Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro
  publication-title: Cancer Chemother. Pharmacol.
  doi: 10.1007/s00280-018-3543-6
– volume: 147
  start-page: 705
  issue: 3
  year: 2017
  ident: 10.1016/j.prp.2019.152520_bib0010
  article-title: Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2017.10.001
– volume: 4
  start-page: 257
  issue: 4
  year: 2003
  ident: 10.1016/j.prp.2019.152520_bib0090
  article-title: Targeting the PI3K-Akt pathway in human cancer: rationale and promise
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(03)00248-4
– volume: 101
  start-page: 205
  issue: 2
  year: 2008
  ident: 10.1016/j.prp.2019.152520_bib0065
  article-title: History of the FIGO cancer staging system
  publication-title: Int. J. Gynaecol. Obstet.
  doi: 10.1016/j.ijgo.2007.11.004
– volume: 296
  start-page: 1655
  issue: 5573
  year: 2002
  ident: 10.1016/j.prp.2019.152520_bib0025
  article-title: The phosphoinositide 3-kinase pathway
  publication-title: Science
  doi: 10.1126/science.296.5573.1655
– volume: 27
  start-page: 395
  issue: 4
  year: 2018
  ident: 10.1016/j.prp.2019.152520_bib0015
  article-title: Common genetic variation and susceptibility to ovarian cancer: current insights and future directions
  publication-title: Cancer Epidemiol. Biomarkers Prev.
  doi: 10.1158/1055-9965.EPI-17-0315
– volume: 121
  start-page: 664
  issue: Pt 5
  year: 2008
  ident: 10.1016/j.prp.2019.152520_bib0135
  article-title: Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer
  publication-title: J. Cell. Sci.
  doi: 10.1242/jcs.013029
– volume: 9
  start-page: 27220
  issue: 43
  year: 2018
  ident: 10.1016/j.prp.2019.152520_bib0100
  article-title: Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.25513
– volume: 39
  start-page: 689
  issue: 8
  year: 2015
  ident: 10.1016/j.prp.2019.152520_bib0075
  article-title: Epithelial-mesenchymal transition (EMT) gene variants and epithelial ovarian cancer (EOC) risk
  publication-title: Genet. Epidemiol.
  doi: 10.1002/gepi.21921
– volume: 22
  start-page: 880
  issue: 5
  year: 2013
  ident: 10.1016/j.prp.2019.152520_bib0020
  article-title: Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer
  publication-title: Cancer Epidemiol. Biomarkers Prev.
  doi: 10.1158/1055-9965.EPI-12-1030-T
– volume: 11
  start-page: 2875
  issue: 8
  year: 2005
  ident: 10.1016/j.prp.2019.152520_bib0085
  article-title: Frequent mutation of the PIK3CA gene in ovarian and breast cancers
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-04-2142
SSID ssj0007041
Score 2.2374053
Snippet The PI3K pathway is an important signaling network that regulates key cell functions such as cell growth, proliferation and survival. PIK3CA mutations are...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 152520
SubjectTerms Adult
Aged
Aged, 80 and over
Alcohol Drinking - adverse effects
Asian Continental Ancestry Group
Class I Phosphatidylinositol 3-Kinases - genetics
Female
Gene-Environment Interaction
Humans
Middle Aged
Obesity - complications
Ovarian cancer
Ovarian Neoplasms - genetics
Parity
PIK3CA
Polymorphism, Single Nucleotide
Risk Factors
Single nucleotide polymorphism
Smoking - adverse effects
Title Single nucleotide polymorphism of PIK3CA and its interaction with the environment are risk factors for Chinese Han ovarian cancer
URI https://dx.doi.org/10.1016/j.prp.2019.152520
https://www.ncbi.nlm.nih.gov/pubmed/31288947
https://www.proquest.com/docview/2255469400
Volume 215
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhhdJL6bvbR5hCTwV37ZVkWcdladg0JBTSQG5CskfgsrWXXafHQv95Z_xIW2hz6MnYSNhoxjPfaEbzCfFW-ywzobRJzFOfKI8h8UWOiQ8hZtJkaCrehzw7z9eX6uOVvjoQq-ksDJdVjrZ_sOm9tR6fzMfVnG_ren7BzepSyRGHZMfGcbtShrX8_fdfZR4m7dkreXDCo6fMZl_jte1bVma2ZwFiyu-_-6Z_Yc_eBx0_EPdH8AjL4fseigNsHom7Z2N6_LH4cUGOaIPQcJPitqsrhG27oeieFrPef4U2wqeTU7lagm8qqLs9cLeI3XC2AXhLFggPwm-H38DvELj8HEZiHiCQC0y6jXuEtW-g_UbRNl1LVp_dE3F5_OHzap2MHAtJKbXsElVEE7yPyBmXyka_CLpAAgELibHQ3pCXW1hd2TSUhS-qoHyplI8VBXJRhkw-FYdN2-BzAZHRU26twZJgIIkkeJ1jtNrmaHCBM5FOq-vKsQE582Bs3FRp9sWRQBwLxA0CmYl3N1O2Q_eN2warSWTuDxVy5B1um_ZmEq-jX4vzJb7B9nrvyNRplTNz_Ew8G-R-8xWS_HphlXnxfy99Ke7x3VCs9kocdrtrfE3opgtHvfoeiTvLk9P1-U9hdPmK
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhgbaXkD6zfU6hp4K79kqyrWNYGjZNNhSSQG5CskfgsrWXXafHQv95Z_xIW2hz6MlgS1hopJlvNKP5hHinXZJkvjBRSGMXKYc-cnmKkfM-JDJLMCv5HHJ5ni6u1Kdrfb0j5uNdGE6rHHR_r9M7bT28mQ6zOV1X1fSCi9XFkj0OyYaN_PY9RduXaQw-fP-V55HFHX0lt464-Rja7JK81l3NysR0NEDM-f134_Qv8NkZoeMDsT-gRzjqB_hQ7GD9SNxbDvHxx-LHBVmiFULNVYqbtioR1s2K3HuazWr7FZoAn09O5fwIXF1C1W6By0Vs-ssNwGeyQIAQfrv9Bm6DwPnnMDDzAKFcYNZt3CIsXA3NN3K36Vnw-tk8EVfHHy_ni2ggWYgKqWUbqTxk3rmAHHIpTXAzr3MkFDCTGHLtMjJzM6NLE_sid3nplSuUcqEkTy5In8inYrduajwUEBg-pcZkWBAOJJl4p1MMRpsUM5zhRMTj7NpiqEDORBgrO6aafbEkEMsCsb1AJuL9bZd1X37jrsZqFJn9Yw1ZMg93dXs7itfS3uKAiauxudla0nVapUwdPxHPernfjkKSYc-Nyp7_30_fiPuLy-WZPTs5P30hHvCXPnPtpdhtNzf4iqBO6193S_knDqb7GA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Single+nucleotide+polymorphism+of+PIK3CA+and+its+interaction+with+the+environment+are+risk+factors+for+Chinese+Han+ovarian+cancer&rft.jtitle=Pathology%2C+research+and+practice&rft.au=Zhang%2C+Hui&rft.au=Zhou%2C+Li&rft.date=2019-09-01&rft.eissn=1618-0631&rft.volume=215&rft.issue=9&rft.spage=152520&rft_id=info:doi/10.1016%2Fj.prp.2019.152520&rft_id=info%3Apmid%2F31288947&rft.externalDocID=31288947
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0344-0338&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0344-0338&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0344-0338&client=summon